Replies to post #433876 on Amarin Corp Plc (AMRN)

[JRoon71]

The company would have definitely said something if scripts had really jumped in the qtr

They listed script count in the 10K. They went from 705,000 in Q3 to 663,000 in Q4.

Q1 - 726,000
Q2 - 815,000
Q3 - 705,000
Q4 - 663,000

It would appear we will dip below 50% market share in Q4 as well.

EDIT: Also, if we believe their script and revenue numbers, then average script price was $43 in Q3 and $66 in Q4. What sense does that make?

I also wonder if there is some sort of lag between timing of script counts by Symphony Health, versus how Amarin recognizes revenue.

US Scripts................Average Price
Q1.....726,000..........66.25
Q2.....815,000..........53.74
Q3.....705,000..........43.40
Q4.....663,000..........66.66
YR.....2,909,000.......57.30